of ESMO Guidelines: Real Cases – Webinar Series: Uveal Melanoma 2026 scheduled for Wednesday, September 30th 2026, It starts at 18:30 CEST.
As uveal melanoma remains a rare entity that is biologically distinct from cutaneous melanoma, this webinar provides an important platform to present evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens of daily practice.
chairman Olivier Michelin This session will include a multidisciplinary panel of experts including Jorja Braden, Sophie Piperno-Neumann, Eric Saldaña and Mauricio Fernando Silva Almeida Ribeiro. The program focuses on translating recent breakthroughs, such as the efficacy of teventasp, into real-world clinical strategies, addressing implementation barriers, and leveraging molecular profiling to optimize patient management.